Correlation between soluble receptor for advanced glycation end products levels and coronary artery disease in postmenopausal nondiabetic women

Table 3 Multivariate logistic regression analysis

Parameter	SE	P value	OR	95%CI for OR
				Lower	Upper
FH CAD	0.639	0.014a	4.827	1.379	16.904
S. CHOL (mg/dL)	0.017	0.002b	1.055	1.020	1.091
LDL-C (mg/dL)	0.024	0.011a	0.941	0.898	0.986
HC (mg/dL)	0.074	0.00b	0.734	0.635	0.848
sRAGE (pg/mL)	0.001	0.011a	1.001	1.0001	1.003
Lp(a) (μg/mL)	0.001	0.052	0.997	0.994	1.000
HTN	0.571	0.755	1.195	0.390	3.662
HDL-C (mg/dL)	0.040	0.853	0.993	0.918	1.073
TG (mg/dL)	0.008	0.265	0.991	0.976	1.007
hsCRP (μg/mL)	1.037	0.00b	0.023	0.003	0.178

^aP < 0.05.

^bP < 0.01.

CAD: Coronary artery disease; CHOL: Cholesterol; CI: Confidence interval; HC: Homocysteine; HDL-C: High-density lipoprotein cholesterol; hsCRP: High-sensitive C-reactive protein; HTN: Hypertension; LDL-C: Low-density lipoprotein cholesterol; Lp(a): Lipoprotein(a); OR: Odds ratio; SE: Standard error; sRAGE: Soluble receptor for advanced glycation end products; TG: Triglycerides.